-
Founded in:
2021-01-12 -
Country:
China -
Address:
No. 21-1, Gongye Street, Hulin City, Jixi City, Heilongjiang Province (declaration commitment) -
Tax NO.:
91230781MA1CE97561 -
Registered Funds:
60 million yuan -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Zinc sulphate |
Zinc participates in the synthesis and activation of multiple enzymes, plays an important physiological role in protein, nucleic acid synthesis, intestinal protein absorption and digestion, and can promote growth and development; maintains normal appetite and taste by synthesizing taste buds and preventing incomplete keratinization of buccal mucosal epithelial cells; enhances the phagocytic ability, chemotaxis and bactericidal function of phagocytes; reduces free radicals by increasing superoxide dismutase; plays a bactericidal role and accelerates the healing of wounds, burns and ulcers; zinc plays an important role in the metabolism of vitamin A and vision; promotes and maintains sexual function; stabilizes cell membranes; improves tissue energy metabolism and tissue respiration; zinc ions can precipitate protein
More
Zinc participates in the synthesis and activation of multiple enzymes, plays an important physiological role in protein, nucleic acid synthesis, intestinal protein absorption and digestion, and can promote growth and development; maintains normal appetite and taste by synthesizing taste buds and preventing incomplete keratinization of buccal mucosal epithelial cells; enhances the phagocytic ability, chemotaxis and bactericidal function of phagocytes; reduces free radicals by increasing superoxide dismutase; plays a bactericidal role and accelerates the healing of wounds, burns and ulcers; zinc plays an important role in the metabolism of vitamin A and vision; promotes and maintains sexual function; stabilizes cell membranes; improves tissue energy metabolism and tissue respiration; zinc ions can precipitate protein |
7733-02-0 | 10 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Betahistine dihydrochloride |
It has a significant dilating effect on cerebrovascular and cardiovascular systems, especially on the vertebral artery system, significantly increasing the blood flow to the heart, brain and peripheral circulation, improving blood circulation, and lowering systemic blood pressure. In addition, it can increase the blood flow to the cochlea and anterior base, thereby eliminating inner ear vertigo, tinnitus and ear closure, and can also increase capillary permeability, promote the absorption of extracellular fluid, and eliminate lymphatic edema; it can counteract the vasoconstrictive effect of catecholamines and lower arterial pressure, and has an inhibitory effect on plasma coagulation and ADP-induced platelet aggregation, can prolong the time of thrombosis in vitro in rats, and has a slight diuretic effect.
More
It has a significant dilating effect on cerebrovascular and cardiovascular systems, especially on the vertebral artery system, significantly increasing the blood flow to the heart, brain and peripheral circulation, improving blood circulation, and lowering systemic blood pressure. In addition, it can increase the blood flow to the cochlea and anterior base, thereby eliminating inner ear vertigo, tinnitus and ear closure, and can also increase capillary permeability, promote the absorption of extracellular fluid, and eliminate lymphatic edema; it can counteract the vasoconstrictive effect of catecholamines and lower arterial pressure, and has an inhibitory effect on plasma coagulation and ADP-induced platelet aggregation, can prolong the time of thrombosis in vitro in rats, and has a slight diuretic effect. |
5579-84-0 | 21 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Diclofenac sodium |
Extract the name, type (main ingredient or excipient), content, unit, and pharmacological action of the raw material from the above information
More
Extract the name, type (main ingredient or excipient), content, unit, and pharmacological action of the raw material from the above information |
15307-79-6 | 55 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Piracetam |
No specific description provided
More
No specific description provided |
7491-74-9 | 24 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| sulfamethoxazole,SMZ |
|
0 | ||
| Sulfadiazine |
|
68-35-9 | 14 | |
| Trimethoprim |
|
738-70-5 | 44 |